المؤلفون: Kenzo Soejima, Hitoshi Tokuda, Tetsuo Yamaguchi, Shigenori Goto, Takashi Kamigaki, Kouji Yoshimori, Yasuhiro Setoguchi, Yoshimasa Umezato, Katsunada Fujimoto, Toru Kaneko, Akira Mizoo, Shoji Kudoh, Kazuro Iwai

المصدر: Cancer Immunology, Immunotherapy

مصطلحات موضوعية: Interleukin 2, Oncology, Male, medicine.medical_specialty, Cancer Research, Lung Neoplasms, CD3 Complex, medicine.medical_treatment, T-Lymphocytes, Immunology, Adenocarcinoma of Lung, Adenocarcinoma, Lymphocyte Activation, Immunotherapy, Adoptive, Severity of Illness Index, Cohort Studies, Adoptive immunotherapy, Internal medicine, Carcinoma, medicine, T lymphocyte, Immunology and Allergy, Humans, Overall survival, Lung cancer, Cells, Cultured, Advanced lung cancer, Aged, Performance status, business.industry, Cancer, Immunotherapy, Middle Aged, medicine.disease, Antibodies, Neutralizing, Combined Modality Therapy, Treatment Outcome, Carcinoma, Squamous Cell, Additive effect, Interleukin-2, Original Article, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2158d75345868b0b5929f16575c9649c
http://europepmc.org/articles/PMC3448049